Status:
UNKNOWN
Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
Lead Sponsor:
Sun Yat-sen University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
The objective of this study is to evaluate the therapeutic efficacy of autologous bone marrow mesenchymal stem cells (BMSCs) transplantation via portal vein in patients with early and middle stage of ...
Eligibility Criteria
Inclusion
- Aged 18\~60 years.
- Serum HBsAg positive.
- Ultrasonographic evidences of cirrhosis.
Exclusion
- history of moderate to severe hepatic encephalopathy or variceal bleeding during the last two months before enrolment.
- Prothrombin time is less than 30s.
- Cirrhosis caused by other reasons except HBV infection.
- Severe problems in other vital organs(e.g.the heart,renal or lungs).
- Liver tumor on ultrasonography, CT or MRI examination.
- Pregnant or lactating women.
- Imaging evidences of vascular thromboses.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00993941
Start Date
October 1 2009
End Date
April 1 2011
Last Update
December 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, Guangdong, China